Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 296
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN/HYDROCHLOROTHIAZID MYLAN 300MG/12,5MG TBL NOB 56X1
0235429 58/ 096/13-C irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID MYLAN 300MG/12,5MG TBL NOB 28 KAL
0235430 58/ 096/13-C irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID MYLAN 300MG/12,5MG TBL NOB 500
0235431 58/ 096/13-C irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID MYLAN 300MG/12,5MG TBL NOB 14
0235432 58/ 096/13-C irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 100 I
0167335 EU/1/09/583/059 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 50X1 I
0167336 EU/1/09/583/060 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 7 II
0167337 EU/1/09/583/061 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 14 II
0167338 EU/1/09/583/062 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 15 II
0167339 EU/1/09/583/063 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 20 II
0167340 EU/1/09/583/064 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 28 II
0167341 EU/1/09/583/065 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 30 II
0167342 EU/1/09/583/066 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 56 II
0167343 EU/1/09/583/067 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 7 I
0167277 EU/1/09/583/001 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 14 I
0167278 EU/1/09/583/002 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 15 I
0167279 EU/1/09/583/003 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 84 I
0194130 EU/1/09/583/073 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 84 I
0194131 EU/1/09/583/074 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 84 I
0194132 EU/1/09/583/075 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 28 KAL I
0194133 EU/1/09/583/076 irbesartan.pdf irbesartan.pdf C09DA04 R

‹‹ ‹ 5 6 7 8 9 10 11 12 13 14 15 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 15. June 2021 at 01:08
Last update of price and payment data: 1. June 2021 at 01:10